XBiotech Inc.
XBIT
$2.27
-$0.04-1.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -155.92% | -19.80% | 86.50% | -8.82% | -126.71% |
| Total Depreciation and Amortization | -13.90% | -2.73% | 0.92% | 2.31% | 1.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -121.21% | 458.48% | -418.76% | 55.12% | 945.80% |
| Change in Net Operating Assets | 480.73% | 110.36% | -748.09% | 67.16% | -190.35% |
| Cash from Operations | -250.95% | 27.13% | 47.35% | 6.69% | -90.50% |
| Capital Expenditure | 59.52% | 67.46% | 91.87% | 63.14% | 26.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 59.52% | 67.46% | 91.87% | 63.14% | 26.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -100.00% | -100.00% | -201.94% | -- |
| Foreign Exchange rate Adjustments | 128.54% | -270.01% | 656.14% | 117.95% | -397.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.95% | -2.94% | 76.35% | -1,751.57% | -381.60% |